Neat1_2 knockdown accelerated mAKT/NRAS-driven tumor development and shortened the mean survival time to 40 days (Figure 8A-C), which was likely due to further reduction of Neat1_2 expression (Figure 8D). Here, NRAS is linked to neoplasm.